Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma

Clinical trial NCT00773097 · COMPLETED

Trial details

NCT number: NCT00773097
Sponsor: Robert Schoen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Risk for Colorectal Cancer

Start date: 2008-10-01
Primary completion: 2011-10-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.